King Pharmaceuticals KG Legacy Reinsurance — Reinsurance balances receivable, net

Similar metrics at other companies

JRVRReinsurance balances payable

$58.83M-37.7%

SLDEReinsurance balances payable

$68.93M—

ACICReinsurance balances payable

$42.49M-21.0%

HGTYReinsurance balances payable

$203.99M-19.0%

SIEBReinsurance balances payable

$94K-7.8%

THGReinsurance balances payable

$43.4M-5.2%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PremiumsReceivableAtCarryingValue.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's legacy reinsurance — reinsurance balances receivable, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's legacy reinsurance — reinsurance balances receivable, net?: King Pharmaceuticals (KG) reported legacy reinsurance — reinsurance balances receivable, net of $297K in Q1 2026.
What does legacy reinsurance — reinsurance balances receivable, net mean?: Represents the net amount due from other insurance companies for premiums or claims related to reinsurance contracts. This metric highlights the segment's credit exposure to its reinsurance partners.